Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
Clinical trial NCT03099499 · TERMINATED
Trial details
- NCT number
- NCT03099499
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-08
- Primary completion
- 2020-09-09
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.